Page results
-
The Royal National ENT and Eastman Dental Hospitals is one of the UK's largest centres for ENT surgery, it offers a wide range of services from a multidisciplinary team. The ENT out-patient department provides both routine and specialist clinics including some nurse-led clinics. Referral to this service is via your GP.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
Laryngology is part of ENT, it is a surgical specialty for adults and children with throat complaints.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
Complex travel appointments are available through NHS referral or private pay. Please note that an NHS referral is only valid in certain cases.
-
The heart failure service provides comprehensive care for patients with heart failure.
-
The rapid access chest pain clinic provides a quick and early specialist cardiology assessment for patients who need urgent assessment.
-
We provide a wide range of general paediatric services, led by a team of enthusiastic consultants and dedicated nurses.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
File results
-
FOI/2023/0713 - Administration of medicines policies
-
FOI/2023/0717 - Stolen or lost patient property
-
FOI/2023/0729 - In-patient beds and operating theatres
-
FOI/2023/0736 - Placements in locked rehabilitation for adults with mental health diagnosis
-
FOI/2023/0737 - Cancelled appointments at maternity unit from December 2022
-
FOI/2023/0738 - Patients treated with Biologic medicines in gastroenterology
-
FOI/2023/0741 - Anaesthesia Associates staff
-
FOI/2023/0742 - Cancer treatments
-
FOI/2023/0751 - Patient numbers and drug spend for Waldenstrom's Macroglobulinaemia
-
FOI/2023/0752 - Cancer patient deaths whilst on waiting list